BIAF Kronos AI forecast
A 30-trading-day price forecast for bioAffinity Technologies Inc. (BIAF) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts bioAffinity Technologies Inc. at $10.29 on 2026-12-08, +247.6% from the last close of $2.96 on 2026-10-27. Eight out of ten sampled paths end between $8.33 and $13.30, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of BIAF
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $1.97 | $1.72 | $3.08 |
| 2026-11-10 | $4.02 | $2.58 | $5.14 |
| 2026-11-17 | $5.63 | $5.03 | $9.78 |
| 2026-11-24 | $9.12 | $6.64 | $11.15 |
| 2026-12-01 | $9.75 | $7.34 | $14.54 |
| 2026-12-08 | $10.29 | $8.33 | $13.30 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for BIAF?
- Kronos AI's median forecast for BIAF is $10.29 in 30 trading days, +247.6% from the last close, with a 10–90% range of $8.33 to $13.30.
- Is the BIAF Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- IQV — IQVIA Holdings Inc.
- INCY — Incyte Corp.
- MEDP — Medpace Holdings Inc.
- CRL — Charles River Laboratories International Inc.
- ICLR — ICON plc
- ABSI — Absci Corporation